2 domains / 4 areas / 2 specializations
Levitee Labs
Data updated
Levitee Labs Inc. is a British Columbia company that was incorporated on January 23, 2019 and later became listed on the Canadian Securities Exchange under the symbol LVT. Public filings describe it as an integrative wellness company with activities aimed at alternative medicine and the broader psychedelic industry.
The company’s public disclosures frame its role around acquiring and building wellness assets complementary to the evolving psychedelic sector, including clinics, pharmacies, nutraceuticals, and other adjacent healthcare businesses. That makes Levitee Labs relevant as an operator and capital allocator around psychedelic-adjacent healthcare infrastructure rather than a traditional early-stage venture fund.
Clinical Care Delivery Snapshot
Specialty & Outpatient ClinicsProvider Model
Independent Specialty Clinic
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Payer Models
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Seeded from user-provided care-delivery.xlsx list. Contacts: Sakshi Dwivedi (Clinic Manager) Contact emails: hello@leviteelabs.com Contact phones: 1-800-465-8640
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.
Levitee Labs appears to be a public Canadian integrative wellness company with a psychedelic-adjacent mandate, not a conventional venture fund. Its strategy has been described in filings and announcements as building a portfolio of healthcare and wellness assets through acquisitions, with stated focus areas that include addiction services, mental healthcare, and assets complementary to the evolving psychedelic industry. Public records also show financing activity and acquisitions rather than a disclosed standalone venture portfolio.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 2019
- HQ
- Vancouver, British Columbia, Canada
- Website
- Visit